ABBV Dec 2025 140.000 call
| Previous close | 30.35 |
| Open | 41.10 |
| Bid | 29.15 |
| Ask | 31.40 |
| Strike | 140.00 |
| Expiry date | 2025-12-19 |
| Day's range | 30.35 - 41.10 |
| Contract range | N/A |
| Volume | |
| Open interest | 96 |
Insider Monkey12 Undervalued Stocks That Just Raised Their Dividends
In this article, we discuss 12 best dividend stocks that are undervalued and have just raised their payouts. You can skip our detailed analysis of dividend and value stocks and their previous performance, and go directly to read 5 Undervalued Stocks That Just Raised Their Dividends. Dividend stocks didn’t perform well in 2023. However, this […]
PR NewswireAbbVie and Gilgamesh Pharmaceuticals Announce Collaboration and Option-to-License Agreement to Develop Next-Generation Therapies for Psychiatric Disorders
AbbVie (NYSE: ABBV) and Gilgamesh Pharmaceuticals today announced a collaboration and option-to-license agreement to develop next-generation therapies for psychiatric disorders. This collaboration will leverage AbbVie's expertise in psychiatry and Gilgamesh's innovative research platform to discover novel neuroplastogens.
GOBankingRates29 Huge Companies That You’ve Never Heard of Before and Their Stock Prices
You may think you know all of the big, powerful, multinational companies, from Walmart to Apple to Amazon. But you might be surprised at how many companies with tens of billions in annual revenue...
